美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

文藝復興科技持倉

1,954.98

+4.830.25%

漲家數：49

跌家數：45

平家數：2

市盈率：- -

高：1,962.02

開：1,950.49

低：1,950.49

收：1,950.37

資料載入中...

Septerna盤前大漲70%！諾和諾德口服小分子減肥藥牽手成功

BUZZ-先進微器件公司跳漲，宣佈新的 60 億美元股票回購計劃

AMD股價美股盤前漲逾5%

每日经济新闻

BUZZ-Exelixis上調2025年收入預期後股價上漲

AMD 宣佈新的 60 億美元股票回購計劃

AMD(AMD.O)：將回購最多60億美元的股票。

諾和諾德達成口服小分子藥物新合作，總額約22億美元

BUZZ-中美緊張局勢緩解削弱金銀避險吸引力，黃金礦商下跌

盤前異動 | Septerna暴漲63%，將與諾和諾德合作開發口服減肥藥

美股異動 | Septerna(SEPN.US)盤前大漲67% 將與諾和諾德合作開發口服減肥藥

智通财经网

諾和諾德與Septerna達成22億美元協議共同開發新一代減重口服藥

Septerna盤前漲超65% 與諾和諾德合作開發針對肥胖及其他心代謝疾病的口服小分子藥物

諾和諾德達成22億美元交易開發新型減重療法

諾和諾德(NVO)盤前升近2% 諾和諾德中國與平安好醫生達成戰略合作

諾和諾德達成22億美元合作，劍指多靶點口服小分子

医药魔方Info

諾和諾德與美國生物技術公司Septerna達成合作許可協議，將共同開發肥胖症等疾病藥物

聯合健康(UNH.US)新CEO基本年薪為100萬美元遠低於前任

諾和諾德與Septerna達成22億美元協議共同開發新型肥胖症治療方法

新款蔚來ES6 EC6實車曝光或將於5-6月正式亮相

人工智能基礎設施公司 TensorWave 最新融資 1 億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4532/news?page=11"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4532","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","market":"US","secType":"PLATE","nameCN":"文藝復興科技持倉","latestPrice":1955.2001,"timestamp":1747403048584,"preClose":1950.37,"halted":0,"volume":110603522,"delay":0,"changeRate":0.002476,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":4.830078,"latestTime":"05-16 09:44:08 EDT","open":1950.4907,"high":1962.02,"low":1950.4907,"amount":17144891738.00881,"amplitude":0.005911,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1747425600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.530467,"peRate":28.98657,"turnoverRate":0.000871,"increases":46,"decrements":49,"flats":0,"marketCap":21725171989584,"floatMarketCap":20321082613224},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","high":1962.02,"amplitude":0.005911,"preClose":1950.37,"low":1950.4907,"pbRate":"8.530467","latestPrice":1954.9751,"volume":110324142,"delay":0,"open":1950.4907,"prevYearClose":2026.1482,"prevWeekClose":1842.5564,"prevMonthClose":1815.0321,"prevQuarterClose":1820.2863,"fiveDayClose":1842.5564,"twentyDayClose":1709.4374,"sixtyDayClose":2062.4106,"secType":"PLATE","market":"US","turnoverRate":0.000869,"peRate":28.98657,"marketCap":21724454028560,"floatMarketCap":20320523211816,"timestamp":1747403043537,"nameCN":"文藝復興科技持倉"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4532\",,,,undefined,":{"bkCode":"BK4532","up":49,"down":45,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4532\",pageSize:20,pageCount:11,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535288663","title":"Septerna盤前大漲70%！諾和諾德口服小分子減肥藥牽手成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2535288663","media":"Jo的随笔","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535288663?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 21:22","pubTimestamp":1747228921,"startTime":"0","endTime":"0","summary":"诺和诺德最终在小分子口服减肥药赛道，选择了Septerna。根据协议，Septerna 将从诺和诺德获得约 22 亿美元预付款及研发和商业里程碑付款，其中包括超 2 亿美元的预付款和近期里程碑付款。此外，Septerna 还将获得已上市产品全球净销售额的分级特许权使用费。Septerna 有权选择参与合作中一项项目的全球利润分成，替代该产品候选物未来的里程碑付款和特许权使用费。歌礼all in小分子口服减肥药，高剂量临床结果呼之欲出！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515055837a47ea9cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515055837a47ea9cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","LU1093756168.USD","BK4588","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4007","BK4585","LU0154236417.USD","LU1093756325.SGD","SEPN","BK4599"],"gpt_icon":1},{"id":"2535240770","title":"BUZZ-先進微器件公司跳漲，宣佈新的 60 億美元股票回購計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2535240770","media":"路透中文","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535240770?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 21:10","pubTimestamp":1747228200,"startTime":"0","endTime":"0","summary":"BUZZ-先进微器件公司跳涨，宣布新的 60 亿美元股票回购计划5月14日 - ** 先进微设备公司AMD.O股价盘前上涨5.7%至119.02美元** AMD宣布新的60亿美元股票回购计划   ** 公司称，新的授权是对截至 3 月 29 日约 40 亿美元余额的补充。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2002e7c41b0fd3e91e69d7effa2fd7ba","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4S3RM173:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0004445239.USD","LU2458330169.SGD","BK4529","LU0082616367.USD","LU0823421333.USD","BK4532","LU1951200564.SGD","LU2098885051.SGD","LU0979878070.USD","IE00B5949003.HKD","BK4573","BK4575","BK4612","LU0390134368.USD","LU1852331112.SGD","LU1303367103.USD","LU1923623000.USD","LU1064131342.USD","LU1880398554.USD","BK4141","LU0127658192.USD","BK4605","LU1316542783.SGD","LU2360106780.USD","AMD","LU0719512351.SGD","IE00BMPRXN33.USD","LU2264538146.SGD","LU0889565833.HKD","BK4512","BK4614","IE0009356076.USD","LU0823434740.USD","LU0198837287.USD","LU0056508442.USD","LU1951198990.SGD","LU0823421416.USD","LU2458330243.SGD","LU1803068979.SGD","BK4534","LU0109392836.USD","LU0823434583.USD","LU2054465674.USD","LU1988902786.USD","LU1242518857.USD","IE00BMPRXR70.SGD","BK4585","BK4554","BK4543"],"gpt_icon":0},{"id":"2535977022","title":"AMD股價美股盤前漲逾5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535977022","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535977022?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 21:05","pubTimestamp":1747227933,"startTime":"0","endTime":"0","summary":"AMD股价美股盘前涨逾5%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202505143404628581.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202505143404628581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1923623000.USD","LU0979878070.USD","LU1951200564.SGD","IE00BMPRXR70.SGD","LU1316542783.SGD","BK4141","LU1303367103.USD","LU2458330243.SGD","LU2098885051.SGD","LU0642271901.SGD","LU0823434583.USD","LU1951198990.SGD","LU2054465674.USD","LU0056508442.USD","LU0823434740.USD","BK4534","BK4512","LU0109392836.USD","LU1880398554.USD","LU0719512351.SGD","IE0009356076.USD","BK4554","LU0390134368.USD","BK4543","GFS","BK4588","LU1989764664.SGD","BK4612","LU0823421333.USD","LU1880398471.USD","LU2250418816.HKD","IE0004445239.USD","LU1803068979.SGD","LU0889565833.HKD","LU1242518857.USD","LU0823421416.USD","IE00BMPRXN33.USD","LU1988902786.USD","IE00B5949003.HKD","BK4614","LU2264538146.SGD","LU2360106780.USD","AMD","BK4532","LU0127658192.USD","LU1852331112.SGD","BK4585","LU0198837287.USD","BK4605","BK4566"],"gpt_icon":0},{"id":"2535242060","title":"BUZZ-Exelixis上調2025年收入預期後股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2535242060","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535242060?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 21:05","pubTimestamp":1747227916,"startTime":"0","endTime":"0","summary":"BUZZ-Exelixis上调2025年收入预期后股价上涨5月14日 - ** 癌症药物制造商ExelixisEXEL.O股价盘前上涨5.6%至39美元** 该公司在周二晚些时候将2025年的营收预期上调至22.5亿至23.5亿美元，之前的预期为21.5亿至22.5亿美元。** 截至上次收盘，股价累计上涨 11 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4S3RM16K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"gpt_icon":0},{"id":"2535024172","title":"AMD 宣佈新的 60 億美元股票回購計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2535024172","media":"路透中文","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535024172?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 21:03","pubTimestamp":1747227828,"startTime":"0","endTime":"0","summary":"AMD 宣布新的 60 亿美元股票回购计划路透5月14日 - 芯片巨头AMD(超威/超微) AMD.O周三表示，公司董事会已经批准了一项新的60亿美元的股票回购计划，从而将公司的股票回购授权总额提高到约100亿美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2002e7c41b0fd3e91e69d7effa2fd7ba","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4T3RM16C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0004445239.USD","LU2458330169.SGD","LU0081259029.USD","BK4529","LU0823421333.USD","LU1951200564.SGD","BK4532","LU0979878070.USD","IE00B5949003.HKD","BK4573","BK4575","BK4612","LU0390134368.USD","LU1852331112.SGD","LU1923623000.USD","LU1064131342.USD","LU1880398471.USD","LU1880398554.USD","LU1989764664.SGD","BK4141","LU2250418816.HKD","BK4605","LU1316542783.SGD","LU2360106780.USD","AMD","LU0719512351.SGD","IE00BMPRXN33.USD","LU2264538146.SGD","LU0889565833.HKD","LU1242518931.SGD","BK4512","IE0009356076.USD","LU0642271901.SGD","LU0823434740.USD","LU0198837287.USD","LU0056508442.USD","LU0823421416.USD","LU2458330243.SGD","LU1803068979.SGD","BK4566","BK4534","LU0109392836.USD","LU2054465674.USD","LU1988902786.USD","LU1242518857.USD","IE00BMPRXR70.SGD","BK4585","BK4554","BK4543"],"gpt_icon":0},{"id":"2535249250","title":"AMD(AMD.O)：將回購最多60億美元的股票。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535249250","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535249250?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 21:00","pubTimestamp":1747227637,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"faa7ab872ee8caf59b3e74c50ca94186","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4612","LU0198837287.USD","LU0979878070.USD","AMD","LU1316542783.SGD","LU1242518931.SGD","LU0719512351.SGD","IE00BMPRXN33.USD","LU0823421333.USD","LU0056508442.USD","BK4543","BK4588","BK4141","LU1880398554.USD","LU1923623000.USD","LU1803068979.SGD","LU1988902786.USD","BK4614","GFS","LU0823421416.USD","BK4585","BK4534","LU0109392836.USD","LU0390134368.USD","LU1880398471.USD","LU0642271901.SGD","LU2264538146.SGD","LU1303367103.USD","LU0127658192.USD","LU1242518857.USD","LU2360106780.USD","LU1951198990.SGD","LU0081259029.USD","BK4554","LU2458330169.SGD","LU1064131342.USD","BK4573","LU2458330243.SGD","LU2250418816.HKD","LU0823434583.USD","LU0889565833.HKD","LU0823434740.USD","BK4532","BK4575","LU2054465674.USD","IE0004445239.USD","LU0082616367.USD","BK4605","BK4566","LU1989764664.SGD"],"gpt_icon":0},{"id":"2535102476","title":"諾和諾德達成口服小分子藥物新合作，總額約22億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535102476","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535102476?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 21:00","pubTimestamp":1747227623,"startTime":"0","endTime":"0","summary":"本文来源：时代财经5月14日，时代财经获悉，诺和诺德对外宣布，与Septerna达成一项独家全球合作及许可协议，双方将共同致力于发现、开发并商业化针对肥胖症、2型糖尿病及其他心脏代谢疾病的口服小分子药物。根据协议条款，Septerna将有资格从诺和诺德获得总计约22亿美元的付款，其中有超2亿美元为预付款及近期里程碑付款。Septerna还可获得上市产品的分层特许权使用费。另外，据悉，诺和诺德将承担合作项目的全部研发费用。（时代财经 张羽岐）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421021094f6c08a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421021094f6c08a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","BK4007","BK4599","BK4585","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","LU1093756325.SGD","BK4532","BK4588","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2535021524","title":"BUZZ-中美緊張局勢緩解削弱金銀避險吸引力，黃金礦商下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2535021524","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535021524?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 20:43","pubTimestamp":1747226638,"startTime":"0","endTime":"0","summary":"** 加拿大矿商Kinross Gold KGC.N和Agnico Eagle Mines AEM.N分别下跌1.3%和1%。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4S3RM156:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4017","LU0075056555.USD","LU0456854461.SGD","BK4570","LU1023059493.AUD","LU0788108826.HKD","LU0654597011.USD","LU0724618789.USD","LU0300736062.USD","LU1223083913.SGD","LU0788109121.HKD","LU2498475776.HKD","BK4585","LU0278409577.USD","LU0266512127.USD","LU1883866441.USD","LU0345780521.USD","LU0368265764.SGD","BK4533","LU1430597077.USD","LU0345780281.USD","NEM","LU1223082196.USD","LU0612318971.USD","SG9999001143.SGD","LU0496367417.USD","LU1223082519.USD","LU2462611646.USD","BK4532","LU0330918003.SGD","LU1280957306.USD","LU0300736492.USD","LU0498741890.SGD","LU0640476718.USD","LU0498741114.HKD","LU0612318385.USD","BK4588","LU0055631609.USD"],"gpt_icon":0},{"id":"2535029024","title":"盤前異動 | Septerna暴漲63%，將與諾和諾德合作開發口服減肥藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2535029024","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535029024?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 20:42","pubTimestamp":1747226528,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺和诺德同意与Septerna共同开发和商业化用于治疗肥胖症和其他心脏代谢疾病的口服小分子药物，交易价值高达22亿美元。受该消息影响，Septerna盘前大涨67%。作为交易的一部分，该公司将从诺和诺德获得超过2亿美元的预付款和近期里程碑付款。诺和诺德向Septerna支付的总金额可能达到22亿美元，包括预付款以及研发和商业里程碑付款。","market":"sh","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1293255.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Septerna将与诺和诺德合作开发口服减肥药","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4532","LU1093756168.USD","NVO","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4007","IE00BKVL7J92.USD","BK4588","BK4599","BK4585","SEPN"],"gpt_icon":0},{"id":"2535602161","title":"美股異動 | Septerna(SEPN.US)盤前大漲67% 將與諾和諾德合作開發口服減肥藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2535602161","media":"智通财经网","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535602161?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 20:34","pubTimestamp":1747226040,"startTime":"0","endTime":"0","summary":"诺和诺德同意与Septerna共同开发和商业化用于治疗肥胖症和其他心脏代谢疾病的口服小分子药物，交易价值高达22亿美元。受该消息影响，Septerna盘前大涨67%。作为交易的一部分，该公司将从诺和诺德获得超过2亿美元的预付款和近期里程碑付款。诺和诺德向Septerna支付的总金额可能达到22亿美元，包括预付款以及研发和商业里程碑付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-14/doc-inewpwew0285573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1093756168.USD","BK4588","BK4599","SEPN","IE00BKVL7J92.USD","BK4585","LU0154236417.USD","LU1093756325.SGD","BK4532","BK4007","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2535211680","title":"諾和諾德與Septerna達成22億美元協議 共同開發新一代減重口服藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2535211680","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535211680?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 20:32","pubTimestamp":1747225926,"startTime":"0","endTime":"0","summary":"格隆汇5月14日｜诺和诺德周三宣布，与美国生物技术公司Septerna达成价值高达22亿美元的合作与授权协议，将共同开发针对肥胖、第二型糖尿病及其他心脏代谢疾病的口服小分子新药。这笔交易包含超过2亿美元的预付款及短期付款，未来潜在价值最高可达22亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514203218975976fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514203218975976fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","BK4585","IE00BKVL7J92.USD","BK4599","LU1093756168.USD","NVO","BK4588","BK4007","IE00BZ1G4Q59.USD","LU1093756325.SGD","SEPN","BK4532"],"gpt_icon":0},{"id":"2535298400","title":"Septerna盤前漲超65% 與諾和諾德合作開發針對肥胖及其他心代謝疾病的口服小分子藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2535298400","media":"金吾资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535298400?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 20:20","pubTimestamp":1747225205,"startTime":"0","endTime":"0","summary":"金吾财讯 | Septerna(SEPN)盘前股价暴力拉升，暂涨65.92%，报11.16美元。消息面上，公司与诺和诺德达成合作与许可协议，共同开发用于治疗肥胖症、2型糖尿病和其他心脏代谢疾病的口服小分子药物。诺和诺德是广受欢迎的减肥药Wegovy的制造商，该公司试图通过开发下一代药物、收购和合作来进一步巩固其在潜在的1500亿美元肥胖症市场中的地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051420204294f6b68a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051420204294f6b68a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","BK4007","BK4585","LU0154236417.USD","LU1093756325.SGD","LU1093756168.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","SEPN","BK4599"],"gpt_icon":0},{"id":"2535276230","title":"諾和諾德達成22億美元交易 開發新型減重療法","url":"https://stock-news.laohu8.com/highlight/detail?id=2535276230","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535276230?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 20:07","pubTimestamp":1747224461,"startTime":"0","endTime":"0","summary":"【诺和诺德达成22亿美元交易 开发新型减重疗法】欧洲当地时间5月14日，诺和诺德宣布，已与美国生物技术公司Septerna达成合作及许可协议，共同开发用于治疗肥胖症、2型糖尿病和其他心脏代谢疾病的口服小分子药物，该协议价值预计高达22亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505143404602184.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505143404602184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK4532","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007","IE00BKVL7J92.USD","LU1093756325.SGD","BK4599","LU0154236417.USD","NVO","BK4588"],"gpt_icon":0},{"id":"2535255730","title":"諾和諾德(NVO)盤前升近2% 諾和諾德中國與平安好醫生達成戰略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2535255730","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535255730?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 19:56","pubTimestamp":1747223800,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德(NVO)盘前股价走高，暂升1.94%，报66.67美元。平安好医生(01833.HK)与诺和诺德中国宣布达成战略合作，双方将结合在肥胖症管理及公众健康教育领域的各自优势，共同构建覆盖“认知提升—诊疗干预—长期管理”的全周期服务闭环，推动科学减重理念。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/Mjg1NzQ1OGJhMDJiZWVjMjcxYjFlYjJjMTY3ODIxNTA4Njc=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Mjg1NzQ1OGJhMDJiZWVjMjcxYjFlYjJjMTY3ODIxNTA4Njc=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"288505","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","IE00BZ1G4Q59.USD","BK4007","BK4585","BK1219","NVO","LU0154236417.USD","IE00BKVL7J92.USD","01833","LU1093756168.USD","BK1571","BK4599","BK1617","LU1093756325.SGD","BK1142","BK4588","BK1247","BK1615","BK4532"],"gpt_icon":0},{"id":"2535275460","title":"諾和諾德達成22億美元合作，劍指多靶點口服小分子","url":"https://stock-news.laohu8.com/highlight/detail?id=2535275460","media":"医药魔方Info","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535275460?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 19:53","pubTimestamp":1747223597,"startTime":"0","endTime":"0","summary":"5月14日，诺和诺德与Septerna宣布达成一项独家全球合作及许可协议，双方将共同致力于发现、开发并商业化针对肥胖症、2型糖尿病及其他心脏代谢疾病的口服小分子药物。根据协议条款，Septerna将有资格从诺和诺德获得总计约22亿美元的付款，包括首付款及研发、商业化里程碑款项，其中超过2亿美元为预付款及近期里程碑付款。自IND申报阶段起，诺和诺德将独家负责全球开发及商业化工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514211119a47e393d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514211119a47e393d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4599","IE00BKVL7J92.USD","BK4007","NVO","BK4588","BK4532","BK4585"],"gpt_icon":0},{"id":"2535025717","title":"諾和諾德與美國生物技術公司Septerna達成合作許可協議，將共同開發肥胖症等疾病藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2535025717","media":"界面","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535025717?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 19:53","pubTimestamp":1747223589,"startTime":"0","endTime":"0","summary":"5月14日，诺和诺德公司宣布，其与美国生物技术公司Septerna达成了一项合作与许可协议，将共同开发治疗肥胖症、2型糖尿病和其他心血管疾病的口服小分子药物。诺和诺德表示，Septerna公司将有资格获得约22亿美元的收益，其中包括超2亿美元的前期和近期付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514195309a6deea57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514195309a6deea57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","LU1093756168.USD","SEPN","BK4585","LU1093756325.SGD","BK4588","NVO","IE00BKVL7J92.USD","BK4007"],"gpt_icon":0},{"id":"2535025589","title":"聯合健康(UNH.US)新CEO基本年薪為100萬美元 遠低於前任","url":"https://stock-news.laohu8.com/highlight/detail?id=2535025589","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535025589?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 19:49","pubTimestamp":1747223377,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，联合健康周三公布新任首席执行官Stephen Hemsley的基本年薪将为100万美元，在此之前，该公司宣布Andrew Witty因个人原因辞去首席执行官一职。现年72岁的Hemsley担任该公司的董事会主席，并曾经担任首席执行官。在Witty周一突然离职后，Hemsley被联合健康任命为首席执行官，任命立即生效。尽管Hemsley同时担任联合健康董事长和首席执行官，但他将不再以董事身份领取薪酬。Witty在2024年的基本工资为150万美元。截至发稿，联合健康盘前涨2.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3a8730fee8191154e1f1a3043d05ab53","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1293220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2236285917.USD","LU1023059063.AUD","LU0149725797.USD","LU0029864427.USD","BK4585","IE00B19Z8W00.USD","LU1670628061.USD","IE00B2B36J28.USD","SG9999013999.USD","IE00B1XK9C88.USD","LU0965508806.USD","IE0002141913.USD","LU1934455194.USD","LU2112291526.USD","LU2089284900.SGD","LU2244417387.USD","IE00B19Z3B42.SGD","LU0052756011.USD","IE00BN29S564.USD","LU0943347566.SGD","LU1551013342.USD","LU1670627923.USD","LU0820561818.USD","LU2133065610.SGD","LU0672654240.SGD","LU1261432733.SGD","LU2089283258.USD","LU0077335932.USD","IE00BFSS7M15.SGD","LU0011850046.USD","IE00B19Z9505.USD","IE00B19Z3581.USD","LU1035773651.USD","LU1267930730.SGD","LU0211326755.USD","BK4532","LU0708994859.HKD","LU0795875169.SGD","IE00BFXG1179.USD","LU0109391861.USD","LU1066051225.USD","IE0004445015.USD","IE00B7KXQ091.USD","LU1720051108.HKD","SG9999014898.SGD","LU0683600562.USD","LU1674673428.USD","LU1720051017.SGD","UNH","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2535461023","title":"諾和諾德與Septerna達成22億美元協議 共同開發新型肥胖症治療方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2535461023","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535461023?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 19:42","pubTimestamp":1747222978,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德(NVO)周三表示，已与美国生物技术公司Septerna达成合作与许可协议，共同开发用于治疗肥胖症、2型糖尿病和其他心脏代谢疾病的口服小分子药物。诺和诺德是广受欢迎的减肥药Wegovy的制造商，该公司试图通过开发下一代药物、收购和合作来进一步巩固其在潜在的1500亿美元肥胖症市场中的地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051419444594f6ae1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051419444594f6ae1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","NVO","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4585","SEPN","IE00BKVL7J92.USD","LU0154236417.USD","BK4007","BK4532","LU1093756168.USD","BK4588"],"gpt_icon":0},{"id":"2535074297","title":"新款蔚來ES6 EC6實車曝光 或將於5-6月正式亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=2535074297","media":"车评网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535074297?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 19:00","pubTimestamp":1747220415,"startTime":"0","endTime":"0","summary":"近日，一组新款蔚来ES6和EC6的实车谍照在网络上曝光，引发业界关注。据知情人士透露，新车将基于升级后的NT2.5平台打造，预计最快将于今年第二季度正式上市。现款ES6和EC6均搭载前后双电机系统，前电机最大功率150千瓦，后电机最大功率210千瓦，综合输出功率达490马力，峰值扭矩700牛·米。续航方面提供75kWh、100kWh和150kWh三种电池组选择，现款ES6的CLTC续航里程分别为500公里、625公里和930公里，EC6则为505公里、630公里和935公里。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514231752a47e550f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514231752a47e550f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK4531","BK4526","BK4574","09866","BK4548","NIO","BK4505","BK4099","BK4509","BK4555","BK4504","BK4588","BK4581","NIO.SI","EVS.SI","BK4585","LU0052750758.USD","LU0708995583.HKD","BK4532","BK4534"],"gpt_icon":1},{"id":"2535939042","title":"人工智能基礎設施公司 TensorWave 最新融資 1 億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535939042","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535939042?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 19:00","pubTimestamp":1747220413,"startTime":"0","endTime":"0","summary":"人工智能基础设施公司 TensorWave 最新融资 1 亿美元路透5月14日 - 总部位于拉斯维加斯的初创公司 TensorWave 周三宣布，该公司在最新一轮融资中获得了 1 亿美元的资金，目的是利用迅速扩大的人工智能基础设施市场。\"该公司表示：\"此次融资正值人工智能基础设施市场经历前所未有的增长之际，最近的行业报告预计，到2027年，人工智能基础设施市场将超过4000亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4T3RM0ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1988902786.USD","LU2054465674.USD","BK4141","LU1242518931.SGD","LU0719512351.SGD","LU0109392836.USD","IE0009356076.USD","LU0979878070.USD","LU1989764664.SGD","BK4588","LU1880398471.USD","LU1951200564.SGD","LU0198837287.USD","LU0823421416.USD","LU1951198990.SGD","BK4575","LU1064131342.USD","IE00BMPRXR70.SGD","LU0889565833.HKD","LU2250418816.HKD","LU0082616367.USD","LU2458330169.SGD","BK4534","BK4532","LU0056508442.USD","LU1880398554.USD","LU2098885051.SGD","LU0081259029.USD","BK4612","LU2264538146.SGD","LU1852331112.SGD","LU0823434583.USD","BK4554","BK4543","LU2458330243.SGD","BK4512","LU1923623000.USD","BK4573","BK4605","LU0823434740.USD","LU1316542783.SGD","LU2360106780.USD","BK4614","IE00BMPRXN33.USD","LU0127658192.USD","LU0390134368.USD","AMD","LU1303367103.USD","BK4566","LU0642271901.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":47,"pageCount":11,"totalSize":937,"code":"91000000","status":"200"}]}}